JA-Robert Wallis - The Aurum Institute

TCA metabolism regulates DNA hypermethylation in LPS and Mycobacterium tuberculosis-induced immune tolerance.

Abhimanyu, Longlax, S.C., Nishiguchi, T., Ladki, M., Sheikh, D., Martinez, A.L., Mace, E.M., Grimm, S.L., Caldwell, T., Portillo Varela, A. and Sekhar, R.V., 2024. TCA metabolism regulates DNA hyperme...
Adjunctive N-Acetylcysteine and Lung Function in Pulmonary Tuberculosis.

Wallis, R.S., Sabi, I., Lalashowi, J., Bakuli, A., Mapamba, D., Olomi, W., Siyame, E., Ngaraguza, B., Chimbe, O., Charalambous, S. and Rachow, A., 2024. Adjunctive N-acetylcysteine and lung function i...
Repurposing N-acetylcysteine for management of non-acetaminophen induced acute liver failure: an evidence scan from a global health perspective.

Jerome, R.N., Zahn, L.A., Abner, J.J., Joly, M.M., Shirey-Rice, J.K., Wallis, R.S., Bernard, G.R. and Pulley, J.M., 2024. Repurposing N-acetylcysteine for management of non-acetaminophen induced acute...
Circulating Biomarkers, Fraction of Exhaled Nitric Oxide, and Lung Function in Patients With Human Immunodeficiency Virus and Tuberculosis.

Maenetje, P., Baik, Y., Schramm, D.B., Vangu, M.D.T.W., Wallis, R.S., Mlotshwa, M., Tiemessen, C.T., Li, Y., Kornfeld, H., Churchyard, G. and Auld, S.C., 2024. Circulating Biomarkers, Fraction of Exha...
Repurposing N-acetylcysteine for management of non-acetaminophen induced acute liver failure: an evidence scan from a global health perspective

Jerome, R.N., Zahn, L.A., Abner, J.J., Joly, M.M., Shirey-Rice, J.K., Wallis, R.S., Bernard, G.R. and Pulley, J.M., 2024. Repurposing N-acetylcysteine for management of non-acetaminophen induced acute...
N-acetylcysteine modulates markers of oxidation, inflammation and infection in tuberculosis.

Mapamba, D.A., Sabi, I., Lalashowi, J., Sauli, E., Buza, J., Olomi, W., Mtafya, B., Kibona, M., Bakuli, A., Rachow, A. and Velen, K., 2025. N-acetylcysteine modulates markers of oxidation, inflammati...
A Prospective, Randomised, Open Label Phase 2b Dose-Finding Trial of Delpazolid in Combination with Bedaquiline, Delamanid and Moxifloxacin for Pulmonary Tuberculosis: DECODE

Minja, L.T., van der Feltz, I., Manyama, C., Mpagama, S., Mhimbira, F., Noreña, I., Sebe, M., Rassool, M., Wallis, R., Ntinginya, N.E. and Liyoyo, A., A Prospective, Randomised, Open Label Phase 2b D...
Cardiac safety of bedaquiline, delamanid and moxifloxacin co-administered with or without varying doses of sutezolid or delpazolid for the treatment of drug-susceptible TB

Koele, S.E., Stoycheva, K., Mtweve, C., Manyama, C., Mpagama, S., Mhimbira, F., Wallis, R., Ntinginya, N.E., Liyoyo, A., Huglin, B. and Minja, L.T., 2025. Cardiac safety of bedaquiline, delamanid and...

TCA metabolism regulates DNA hypermethylation in LPS and Mycobacterium tuberculosis-induced immune tolerance.

Adjunctive N-Acetylcysteine and Lung Function in Pulmonary Tuberculosis.

Repurposing N-acetylcysteine for management of non-acetaminophen induced acute liver failure: an evidence scan from a global health perspective.

Circulating Biomarkers, Fraction of Exhaled Nitric Oxide, and Lung Function in Patients With Human Immunodeficiency Virus and Tuberculosis.

Repurposing N-acetylcysteine for management of non-acetaminophen induced acute liver failure: an evidence scan from a global health perspective

N-acetylcysteine modulates markers of oxidation, inflammation and infection in tuberculosis.

A Prospective, Randomised, Open Label Phase 2b Dose-Finding Trial of Delpazolid in Combination with Bedaquiline, Delamanid and Moxifloxacin for Pulmonary Tuberculosis: DECODE

Cardiac safety of bedaquiline, delamanid and moxifloxacin co-administered with or without varying doses of sutezolid or delpazolid for the treatment of drug-susceptible TB

Popular Tags

Most Read

Recent Posts